The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor

Baloxavir marboxil (BXM) is an FDA-approved antiviral prodrug for the treatment of influenza A and B infection and postexposure prophylaxis. The active form, baloxavir acid (BXA), targets the cap-snatching endonuclease (PA) of the influenza virus polymerase complex. The nuclease activity delivers th...

Descripción completa

Detalles Bibliográficos
Autores principales: Todd, Brendan, Tchesnokov, Egor P., Götte, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065212/
https://www.ncbi.nlm.nih.gov/pubmed/33647314
http://dx.doi.org/10.1016/j.jbc.2021.100486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065212/
https://www.ncbi.nlm.nih.gov/pubmed/33647314
http://dx.doi.org/10.1016/j.jbc.2021.100486

Ejemplares similares